BeyHealth Quarterly Journal (BHQJ) BHQJ 2018: 001:1 (May 2018) - Page 17

12:10 – 13:00 Session 3 Investigating Colorectal Cancer – Aetiology, Presentation and Screening Colorectal cancer is a major health problem worldwide with over 750,000 new cases and nearly 300,000 deaths per annum. Mr Obichere considers the true extent of the problem in Nigeria. He discusses screening as an important mechanism for improving prognosis and preventing disease progression, and provides an in-depth overview of diagnosis and evidence-based treatment of colorectal cancers. Speaker: Mr Austin Obichere MD, FRCS, FRCS (Gen) Consultant General / Laparoscopic Colorectal Surgeon, University College London Hospital (UCLH, NHS Trust, UK) 13:00 – 14:00 Lunch Break 14:00 – 14:50 Session 4 Improving cancer symptoms and survival (1) – Neoadjuvant chemotherapy in breast cancer disease Mrs Baffour-Gyawu examines the early use of chemotherapeutic agents in the management of breast cancer disease. She discusses the value of neo-adjuvant treatment in this condition using case examples and scenarios, and explores specific indications, benefits and pitfalls of initiating chemotherapeutic treatment prior to surgical excision of breast tumours. Speaker: 14:50 – 15:30 Mrs Valentina Baffour-Gyawu Cancer Nurse Specialist, BUPA Cromwell Hospital, London Session 5 Colorectal cancers – Risk factors & surgical treatment In the second of his sessions at this conference, Mr Obichere focuses on risk factors for colorectal cancers and specific indications for surgical treatment. He discusses appropriate methods of surgical management depending on type and location of the disease. Speaker: 15:30 – 16:20 Mr Austin Obichere MD, FRCS, FRCS (Gen) Consultant General / Laparoscopic Colorectal Surgeon, University College London Hospital (UCLH, NHS Trust, UK) Session 6 Treating Breast Cancer – Benefits of the Multidisciplinary Team (MDT) Approach Mr Olubowale’s second session focuses on a collaborative and rigorous approach to arriving at evidence-based treatment decisions and the benefits offered by a well-constructed multidisciplinary team (MDT). He illustrates these advantages using example scenarios. He provides considerable insight into the composition and structure of the MDT and discusses the evidence supporting adoption of this approach. Speaker: Mr Olumuyiwa Olubowale MB ChB, FWACS, MSc (Sheffield), FRCSI, FRCSI (Gen Surg) – Consultant Oncoplastic Breast Surgeon, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust 16:20 – 16:30 Q & A DAY TWO Wednesday 9th May 2018 08:00 – 09:00 Registration 09:00 – 09:10 Welcome & Introduction 09:10 – 10:10 Session 1 Cancer and Mental Health – Psychological & social context of malignant disease In this session, Dr Ojo explores the psychological and social context of malignant disease and appropriate models of care relevant to the presentation of terminal illness. He considers prevailing cultural and religious perceptions of cancer with respect to suffering, palliation, death and dying and examines the effects of these complexities on treatment and holistic care of the terminally ill patient. Speaker: Dr Tim Ojo MBBS, MSc, MBA, FinstLM, ILM level 7 Diploma Executive Coaching, SFFFMLM, FRCPsych – Consultant Adult Psychiatrist, Sussex Partnership NHS Foundation Trust, UK